These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31296659)

  • 1. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
    Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
    J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.
    Yu ED; Girardi E; Wang J; Mac TT; Yu KO; Van Calenbergh S; Porcelli SA; Zajonc DM
    J Biol Chem; 2012 Jan; 287(2):1269-78. PubMed ID: 22110136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.
    Zajonc DM; Kronenberg M
    Immunol Rev; 2009 Jul; 230(1):188-200. PubMed ID: 19594637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
    Dasgupta S; Kumar V
    Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.
    Patel O; Pellicci DG; Uldrich AP; Sullivan LC; Bhati M; McKnight M; Richardson SK; Howell AR; Mallevaey T; Zhang J; Bedel R; Besra GS; Brooks AG; Kjer-Nielsen L; McCluskey J; Porcelli SA; Gapin L; Rossjohn J; Godfrey DI
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19007-12. PubMed ID: 22065767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular basis for NKT cell recognition of CD1d-self-antigen.
    Mallevaey T; Clarke AJ; Scott-Browne JP; Young MH; Roisman LC; Pellicci DG; Patel O; Vivian JP; Matsuda JL; McCluskey J; Godfrey DI; Marrack P; Rossjohn J; Gapin L
    Immunity; 2011 Mar; 34(3):315-26. PubMed ID: 21376640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
    Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
    Wun KS; Ross F; Patel O; Besra GS; Porcelli SA; Richardson SK; Keshipeddy S; Howell AR; Godfrey DI; Rossjohn J
    J Biol Chem; 2012 Nov; 287(46):39139-48. PubMed ID: 22995911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular switch in mouse CD1d modulates natural killer T cell activation by α-galactosylsphingamides.
    Wang J; Guillaume J; Janssens J; Remesh SG; Ying G; Bitra A; Van Calenbergh S; Zajonc DM
    J Biol Chem; 2019 Sep; 294(39):14345-14356. PubMed ID: 31391251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
    Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
    Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique interplay between sugar and lipid in determining the antigenic potency of bacterial antigens for NKT cells.
    Girardi E; Yu ED; Li Y; Tarumoto N; Pei B; Wang J; Illarionov P; Kinjo Y; Kronenberg M; Zajonc DM
    PLoS Biol; 2011 Nov; 9(11):e1001189. PubMed ID: 22069376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
    Maricic I; Girardi E; Zajonc DM; Kumar V
    J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen recognition by CD1d-restricted NKT T cell receptors.
    Godfrey DI; Pellicci DG; Patel O; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Semin Immunol; 2010 Apr; 22(2):61-7. PubMed ID: 19945889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
    Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
    J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d.
    Kuylenstierna C; Björkström NK; Andersson SK; Sahlström P; Bosnjak L; Paquin-Proulx D; Malmberg KJ; Ljunggren HG; Moll M; Sandberg JK
    Eur J Immunol; 2011 Jul; 41(7):1913-23. PubMed ID: 21590763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ins and outs of type I iNKT cell development.
    Shissler SC; Webb TJ
    Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidomic scanning of self-lipids identifies headless antigens for natural killer T cells.
    Cheng TY; Praveena T; Govindarajan S; Almeida CF; Pellicci DG; Arkins WC; Van Rhijn I; Venken K; Elewaut D; Godfrey DI; Rossjohn J; Moody DB
    Proc Natl Acad Sci U S A; 2024 Aug; 121(34):e2321686121. PubMed ID: 39141352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
    Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
    Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.